Evidence map›Paper›PMID 28209768›Full record

ArticleCirculation. Heart failure2017

Worsening Renal Function and Mortality in Heart Failure: Causality or Confounding?

Jeffrey M Testani, Meredith A Brisco-Bacik

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Heart failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Biomarkers of Acute and Chronic Kidney Disease.Annual review of physiology · 2019
    Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jeffrey M TestaniFrom the Department of Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT (J.M.T.); and Department of Medicine, Cardiology Division, Lewis Katz School of Medicine at Temple University, Philadelphia, PA (M.A.B.-B.). jeffrey.testani@yale.edu.
Meredith A Brisco-BacikFrom the Department of Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT (J.M.T.); and Department of Medicine, Cardiology Division, Lewis Katz School of Medicine at Temple University, Philadelphia, PA (M.A.B.-B.).

Funding

Cardio-renal phenotype and prognosis in chronic heart failureK23HL114868 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2012 to 2017
$845k
Determining Mechanisms of Renal Dysfunction after Left Ventricular Assist DeviceK23HL128933 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI BRISCO-BACIK, MEREDITH ANN · 2015 to 2019
$831k
NHLBI NIH HHS K23 HL114868NHLBI NIH HHS K23 HL128933NHLBI NIH HHS L30 HL115790
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart FailureRenin-Angiotensin SystemGlomerular Filtration RateHumanscardio-renal syndromeEditorialsglomerular filtration rateheart failureprognosisrenin-angiotensin systemworsening renal function

Identifiers

PMID28209768
PMCPMC5382499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.